TNFRSF25 and glycogen storage disease VI: Some preclinical models showed that activating a tumor necrosis factor receptor superfamily member 25 (TNFRSF25) with or without IL-2 could reduce the graft-vs.-host disease or prevent allergic lung inflammation in mice recipients (50).